Financial and Regulatory
Your smart tech partner in natural health
2022 Q2 Financial Statements
2022 Q2 MD&A
2022 Q3 Financial Statements
2022 Q3 MD&A
Visit us at SEDAR
PanGenomic Prospectus (PDF)
Number of securities in issue and the percentage of securities in public hands.
99,128,169 common shares outstanding 88.6% held publicly.
Particulars of any outstanding instruments issued by the issuer convertible into, or conferring a right to subscribe for, the admitted securities; the amount and percentage of immediate dilution assuming full exercise of rights of conversion.
An exercise price of $0.15 per common share 3,000,000
An exercise price of $0.30 per common share 37,857,713
Exercise prices range from $0.15 to $0.23 per common share 4,010,000
Shareholders holding more than five percent of the issuer's share capital or voting rights and the percentage held by such shareholders
No shareholders currently hold more than 5% of the issuer’s share capital.